cephalosporin c has been researched along with sc002 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Chi, SP; Gao, R; Lei, HM; Li, J; Wang, C; You, LY | 1 |
| Brickman, D; Fong, A; Johnson, M; Lazarov, M; Morgensztern, D; Rossi, M; Rudin, CM | 1 |
1 trial(s) available for cephalosporin c and sc002
| Article | Year |
|---|---|
SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study.
Topics: Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cephalosporins; Humans; Lung Neoplasms; Small Cell Lung Carcinoma | 2020 |
1 other study(ies) available for cephalosporin c and sc002
| Article | Year |
|---|---|
Primary study and anti-tumor mechanisms of analog from SC002.
Topics: Animals; Antineoplastic Agents; Caspases; Cell Line, Tumor; Cell Proliferation; Cephalosporins; Female; Hep G2 Cells; Humans; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Transplantation, Heterologous; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A | 2011 |